Prediction of 2-Year Major Adverse Limb Event-Free Survival After Percutaneous Transluminal Angioplasty and Stenting for Lower Limb Atherosclerosis Obliterans: A Machine Learning-B...

por Pan, Tianyue, Jiang, Xiaolang, Liu, Hao, Liu, Yifan, Fu, Weiguo, Dong, Zhihui
Publicado 2022

Comparison between endovascular aneurysm repair-selected and endovascular aneurysm repair-only strategies for the management of ruptured abdominal aortic aneurysms: An 11-year expe...

por Fang, Gang, Yue, Jianing, Shuai, Tao, Yuan, Tong, Ren, Bichen, Fang, Yuan, Pan, Tianyue, Liu, Zhenjie, Dong, Zhihui, Fu, Weiguo
Publicado 2022

Three‐year outcomes of peripheral blood mononuclear cells vs purified CD34 (+) cells in the treatment of angiitis‐induced no‐option critical limb ischemia and a cost‐effectiveness...

por Liu, Hao, Pan, Tianyue, Fang, Yuan, Fang, Gang, Liu, Yifan, Jiang, Xiaolang, Chen, Bin, Wei, Zheng, Gu, Shiyang, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Publicado 2021

The peripheral blood mononuclear cells versus purified CD34(+) cells transplantation in patients with angiitis-induced critical limb ischemia trial: 5-year outcomes and return to w...

por Liu, Hao, Pan, Tianyue, Liu, Yifan, Fang, Yuan, Fang, Gang, Jiang, Xiaolang, Chen, Bin, Wei, Zheng, Gu, Shiyang, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Publicado 2022

Return to work after cell transplantation in patients with angiitis-induced critical limb ischaemia and factors related: a single-centre retrospective cohort study

por Liu, Hao, Liu, Yifan, Pan, Tianyue, Fang, Yuan, Fang, Gang, Jiang, Xiaolang, Chen, Bin, Wei, Zheng, Gu, Shiyang, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Publicado 2022

Long-Term Outcomes of Peripheral Blood Mononuclear Cells in the Treatment of Angiitis-Induced No-Option Critical Limb-Threatening Ischemia

por Jiang, Xiaolang, Liu, Hao, Pan, Tianyue, Gu, Shiyang, Fang, Yuan, Wei, Zheng, Fang, Gang, Chen, Bin, Jiang, Junhao, Shi, Yun, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Publicado 2021

Autologous Stem Cells Transplantation for No-Option Angiitis-Induced Critical Limb Ischemia: Recurrence and New Lesion

por Liu, Hao, Fang, Yuan, Pan, Tianyue, Fang, Gang, Liu, Yifan, Jiang, Xiaolang, Chen, Bin, Gu, Shiyang, Wei, Zheng, Liu, Peng, Fu, Weiguo, Yang, Jue, Dong, Zhihui
Publicado 2022

Autologous peripheral blood-derived stem cells transplantation for treatment of no-option angiitis-induced critical limb ischemia: 10-year management experience

por Fang, Gang, Jiang, Xiaolang, Fang, Yuan, Pan, Tianyue, Liu, Hao, Ren, Bichen, Wei, Zheng, Gu, Shiyang, Chen, Bin, Jiang, Junhao, Shi, Yun, Guo, Daqiao, Liu, Peng, Fu, Weiguo, Dong, Zhihui
Publicado 2020

A Five‐Year Study of the Efficacy of Purified CD34+ Cell Therapy for Angiitis‐Induced No‐Option Critical Limb Ischemia

por Fang, Yuan, Wei, Zheng, Chen, Bin, Pan, Tianyue, Gu, Shiyang, Liu, Peng, Guo, Daqiao, Xu, Xin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Yifan, Dong, Zhihui, Fu, Weiguo
Publicado 2018

Predictors of responders to mononuclear stem cell-based therapeutic angiogenesis for no-option critical limb ischemia

por Pan, Tianyue, Liu, Hao, Fang, Yuan, Wei, Zheng, Gu, Shiyang, Fang, Gang, Liu, Yifan, Luo, Yang, Guo, Daqiao, Xu, Xin, Chen, Bin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Peng, Dong, Zhihui, Fu, Weiguo
Publicado 2019

Purified CD34(+) cells versus peripheral blood mononuclear cells in the treatment of angiitis-induced no-option critical limb ischaemia: 12-Month results of a prospective randomise...

por Dong, Zhihui, Pan, Tianyue, Fang, Yuan, Wei, Zheng, Gu, Shiyang, Fang, Gang, Liu, Yifan, Luo, Yang, Liu, Hao, Zhang, Tiejun, Hu, Meiyu, Guo, Daqiao, Xu, Xin, Chen, Bin, Jiang, Junhao, Yang, Jue, Shi, Zhenyu, Zhu, Ting, Shi, Yun, Liu, Peng, Fu, Weiguo
Publicado 2018